Searched for
ROCHE INDIA
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Rice University eyes deeper India push, weighs campus presence under NEPRice University is looking at expanding its presence in India. This includes potential research and academic partnerships under the new Nat...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Walmart’s beauty push gets personal with in-store consultationsWalmart is bringing trained beauty experts to its stores. These specialists will offer personalized makeup and skincare advice. This initia...
- Roche India arm leases 2 lakh sq ft office spaceRoche Information Solutions India, the healthcare digital entity of the global pharmaceutical major, will be paying rentals of over ₹210 cr...
- Will antibody cocktail of Roche reduce demand for Tocilizumab: Delhi High CourtThe query was posed to the government by Justice Prathiba M Singh after Roche India, which supplies Tocilizumab in India, told the court it...
- Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of TocilizumabJustice Prathiba M Singh said the officials of the ministry and the department shall hold a meeting with representatives of Roche India and...
- Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...
- Roche India head Lara Bezerra set to exitA Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the d...
- Lara Bezerra to take over as Roche Products India MDLara has over 24 years of experience in the pharmaceutical industry and was earlier the general manager of Roche Venezuela.
- Zydus Cadila launches copy of Roche’s breast cancer drug HerceptinZydus Cadila has introduced a breast cancer drug in India that is a copy of Swiss giant Roche’s product Herceptin, which had global sales o...
- Roche plans to roll out new drugs; plans new market access strategies in India: Maturin Tchoumi, Roche IndiaIndia is a fragmented market and has its own challenges; there is a private sector and public sector. About 80% of the healthcare expenses ...
- Roche plans to step up India play, launches two new medicinesRoche said patients will be offered equated monthly instalment schemes for Perjeta and Kadcyla through financial institutions in the coming...
- India rejects Swiss drug maker Roche Patent claims on Valcyte againIndian authorities have for the second time rejected Swiss drug maker Roche’s patent claims on valganciclovir, or Valcyte, used to treat an...
- Roche cuts Hepatitis C drug cost by 65% for government institutionsDrug major Roche has reduced the prices of its Hepatitis C treatment drug 'Exxura' by 65 per cent across all government institutions in Ind...
- Roche sues Cipla over Valcyte patent breachSwiss major Roche has moved the Bombay High Court (HC) against domestic major Cipla for allegedly infringing both the patent and trademark ...
- Roche signs marketing pact with Elder PharmaRoche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.
Load More
